Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
Eastern Mediterranean Region countries progressed in PMDT using Xpert MTB/RIF, increased diagnosis and treatment of MDR/RR-TB patients using all-oral regimens, and improved treatment success. They must now enhance diagnostic capacity using WHO-recommended diagnostics, decentralise services while integrating them into primary health care, and prioritise the BPaL(M) regimen.
Authors
- Yvan Hutin (ORCID: https://orcid.org/0000-0003-1110-6794)
- Kenza Bennani (ORCID: https://orcid.org/0000-0002-4143-7597)
- Martin van den Boom (ORCID: https://orcid.org/0000-0002-6417-6668)
- Mohammed Gouda ElMedrek (ORCID: https://orcid.org/0009-0001-7142-2353)
Institutions
- World Health Organization Regional Office for the Eastern Mediterranean (EG)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2024-09-01
- DOI
- https://doi.org/10.5588/ijtldopen.24.0348
- Citations
- 5
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.95